Contact this trialFirst, we need to learn more about you.
Virus Therapy
COVID-19 Vaccine for COVID-19
Recruiting1 awardPhase 2
League City, Texas
This trial will study the safety and effectiveness of a single dose of Ad26.COV2.S given to pregnant women in their second or third trimester, and potentially post-partum. Researchers will also study the immune response of these women 28 days after vaccination.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.